OVERVIEW
The global Glycomics / Glycobiology market is set to hit USD 1.62 billion by 2024, rising at a CAGR of 11.23% during the forecast period. Factors such as increased government and private support for glycomics and proteomics research and increased R&D spending by pharmaceutical and biotechnology companies are key drivers for the growth of the glycobiology market.
TABLE OF CONTENT
1 Global Glycomics / Glycobiology MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Glycomics / Glycobiology Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Glycomics / Glycobiology Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Glycomics / Glycobiology Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Glycomics / Glycobiology Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Glycomics / Glycobiology Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Glycomics / Glycobiology Market – By Product (Market Size – & million/billion)
8.1 Enzymes
8.2 Instruments
8.3 Kits
8.4 Reagents
9 Global Glycomics / Glycobiology Market – By Application
9.1 Diagnostics
9.2 Drug Discovery & Development
9.3 Oncology
9.4 Immunology
9.5 Other
10 Global Glycomics / Glycobiology Market – By End-User
10.1 Academic Research Institutes
10.2 Pharmaceutical & Biotechnology Companies
10.3 Contract Research Organizations
11 Global Glycomics / Glycobiology Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Glycomics / Glycobiology Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Glycomics / Glycobiology Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Merck KGaA
13.3 Takara Bio, Inc.
13.4 Shimadzu Corporation
13.5 ProZyme, Inc.
13.6 Thermo Fisher Scientific, Inc.
13.7 Bruker Corporation
13.8 New England Biolabs Inc.
13.9 Agilent Technologies, Inc.
13.10 Waters Corporation
13.11 Danaher Corporation
13.12 Company 11 & more
14 Global Glycomics / Glycobiology Market – Appendix
14.1 Sources
14.2 Abbreviations